AU551427B2 - Novel mono- and bisquaternary ammonium derivatives of 2beta, 16beta-diamino-5alpha-androstane derivatives - Google Patents

Novel mono- and bisquaternary ammonium derivatives of 2beta, 16beta-diamino-5alpha-androstane derivatives

Info

Publication number
AU551427B2
AU551427B2 AU84838/82A AU8483882A AU551427B2 AU 551427 B2 AU551427 B2 AU 551427B2 AU 84838/82 A AU84838/82 A AU 84838/82A AU 8483882 A AU8483882 A AU 8483882A AU 551427 B2 AU551427 B2 AU 551427B2
Authority
AU
Australia
Prior art keywords
derivatives
16beta
2beta
5alpha
diamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU84838/82A
Other languages
English (en)
Other versions
AU8483882A (en
Inventor
Ian Craig Carlyle
David Samuel Savage
Thomas Sleigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of AU8483882A publication Critical patent/AU8483882A/en
Application granted granted Critical
Publication of AU551427B2 publication Critical patent/AU551427B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU84838/82A 1981-06-15 1982-06-11 Novel mono- and bisquaternary ammonium derivatives of 2beta, 16beta-diamino-5alpha-androstane derivatives Ceased AU551427B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8118365 1981-06-15
GB8118365 1981-06-15

Publications (2)

Publication Number Publication Date
AU8483882A AU8483882A (en) 1982-12-23
AU551427B2 true AU551427B2 (en) 1986-05-01

Family

ID=10522526

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84838/82A Ceased AU551427B2 (en) 1981-06-15 1982-06-11 Novel mono- and bisquaternary ammonium derivatives of 2beta, 16beta-diamino-5alpha-androstane derivatives

Country Status (11)

Country Link
US (1) US4447425A (Direct)
EP (1) EP0067480B1 (Direct)
JP (1) JPS5813600A (Direct)
AU (1) AU551427B2 (Direct)
CA (1) CA1186681A (Direct)
DE (1) DE3261364D1 (Direct)
DK (1) DK268382A (Direct)
ES (1) ES513088A0 (Direct)
FI (1) FI72731C (Direct)
HU (1) HU186074B (Direct)
IE (1) IE53463B1 (Direct)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582122B2 (en) * 1983-08-02 1989-03-16 Research Corporation Steroids useful as anti-cancer,anti-obesity, anti-hyperglycemic,anti-autoimmune and anti-hyperchlesterolemic agents

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714481A (en) * 1983-08-02 1998-02-03 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
US5656621A (en) * 1983-08-02 1997-08-12 Research Corporation Tech., Inc. Steroids useful as anti-cancer and anti-obesity agents
US5804576A (en) * 1983-08-02 1998-09-08 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
GB8708886D0 (en) * 1987-04-14 1987-05-20 Akzo Nv 2beta-morpholino-androstane derivatives
GB8804579D0 (en) * 1988-02-26 1988-03-30 Akzo Nv Novel 16-homo-piperidino-androstane derivatives & processes for their preparation
DE4232656C2 (de) * 1992-09-29 1995-01-12 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17-furyl-3ß-derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
KR20070085703A (ko) * 2005-09-13 2007-08-27 시코르, 인크. 로큐로늄 브로마이드의 합성 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138605A (en) * 1965-02-19 1969-01-01 Organon Labor Ltd Improvements in or relating to new 2-ß,16-ß-diamino-androstanes
GB1454749A (en) * 1972-11-29 1976-11-03 Akzo Nv 2beta, 16beta-diamino-androstanes and their preparation
ATE921T1 (de) * 1978-09-05 1982-05-15 Akzo N.V. Saeureadditionssalze von 2-beta, 16-beta-bis-piperidino-an drostan-16-beta-monoquaternaeren ammoniumderivaten und diese enthaltende pharmazeutische zusammensetzungen.
IE50675B1 (en) * 1979-12-12 1986-06-11 Akzo Nv Bis-and mono-quaternary ammonium derivatives of 2beta,16beta-dipiperidino-5alpha-androstanes,processes for their preparation and pharmaceutical preparations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582122B2 (en) * 1983-08-02 1989-03-16 Research Corporation Steroids useful as anti-cancer,anti-obesity, anti-hyperglycemic,anti-autoimmune and anti-hyperchlesterolemic agents

Also Published As

Publication number Publication date
CA1186681A (en) 1985-05-07
DK268382A (da) 1982-12-16
JPS5813600A (ja) 1983-01-26
IE821365L (en) 1982-12-15
ES8308889A1 (es) 1983-08-16
FI72731C (fi) 1987-07-10
FI822131A0 (fi) 1982-06-14
HU186074B (en) 1985-05-28
DE3261364D1 (en) 1985-01-10
EP0067480B1 (en) 1984-11-28
EP0067480A1 (en) 1982-12-22
JPH0249320B2 (Direct) 1990-10-29
US4447425A (en) 1984-05-08
ES513088A0 (es) 1983-08-16
FI72731B (fi) 1987-03-31
AU8483882A (en) 1982-12-23
IE53463B1 (en) 1988-11-23

Similar Documents

Publication Publication Date Title
AU563146B2 (en) N-phenylpyrazoe derivatives useful as herbicides
AU559201B2 (en) Manufacture of ammonia
AU573535B2 (en) Urea derivatives
AU1924183A (en) Phenylethylamine derivatives
AU529982B2 (en) N-substituted aziridine -2-carboxylic acid derivatives
AU552029B2 (en) Derivatives of n-dihydrothiazolyl-3-quinoline
AU551079B2 (en) Glycidyliso cyanuric acid derivatives
AU8483882A (en) Novel mono- and bisquaternary ammonium derivatives of 2beta, 16beta-diamino-5alpha-androstane derivatives
AU517598B2 (en) Derivatives of 1-aza-(2,2,2)-bicyclo-octane
AU556079B2 (en) Guanidine derivatives
AU7251181A (en) Imidazolidinone derivatives
AU560043B2 (en) Guanidine derivatives
AU543951B2 (en) Purification of ammonium tunastate
AU510629B2 (en) Polymorphic form of cimetidine
AU530761B2 (en) Halo-vincamone derivatives
AU583536B2 (en) Pyridyloxy derivatives
AU547570B2 (en) 1-benzylimidazole derivatives
AU2708184A (en) Quaternary ammonium compounds
AU557580B2 (en) 15-cycloaliphatic derivatives of 13,14-didehydro- carboprostacyclins
AU546397B2 (en) Derivatives of estra 4,9-diene
AU528547B2 (en) Phospho betaine derivatives
AU8702182A (en) 1,2-dithiol-3-ylidene ammonium derivatives
JPS57181100A (en) Manufacture of 17 alpha-hydroxy-pregn-4-ene- 3,20-dione derivatives
AU546791B2 (en) Thioalkylamide of nicotinicacid 1-oxide
AU522184B2 (en) Basically substituted urea derivatives